Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Lymphoma, Follicular × Clear all

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell